Levothroid and Folvite drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothroid (levothyroxine sodium) and Folvite (folic acid). Common drug interactions include memory impairment among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Levothroid and Folvite. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

What is Folvite?

Folvite has active ingredients of folic acid. eHealthMe is studying from 2,529 Folvite users. Check the latest studies of Folvite.

On Jul, 16, 2026

39 people who take Levothroid and Folvite together, and have interactions are studied.

Levothroid and Folvite drug interactions.

What are the common drug interactions of Levothroid and Folvite, by gender? *:

female:

Memory impairment
Myalgia (muscle pain)
Nervousness
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Peripheral swelling
Photophobia (extreme sensitivity to light)
Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
Renal impairment (severely reduced kidney function)
Tenderness (pain or discomfort when an affected area is touched)

male:

Cardiac failure congestive
International normalised ratio increased
Influenza
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Pancreatitis chronic (chronic inflammation of pancreas)
Pyrexia (fever)
Viral upper respiratory tract infection
Vomiting
Alcohol abuse

What are the common drug interactions of Levothroid and Folvite, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Fall
Headache (pain in head)
Hypertension (high blood pressure)
Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

Dysarthria (speech disorder)
Gait disturbance
Muscular weakness (muscle weakness)
Neuropathy peripheral (surface nerve damage)
Spasmodic dysphonia (a voice disorder characterized by involuntary movements or spasms of one or more muscles of the larynx)
Speech disorder
Asthenia (weakness)
Cardiac failure congestive
Chest discomfort
Chest pain

60+:

Liver disorder (liver diseases)
Pleural effusion (water on the lungs)
Septic shock (shock due to blood infection)
Urinary tract infection pseudomonal
Visual impairment
Weight decreased
Blood cholesterol increased
Blood phosphorus increased
Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
Drug effect decreased

What are the existing conditions these people have? *

Pain: 15 people, 38.46%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 28.21%
Nausea (feeling of having an urge to vomit): 7 people, 17.95%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 15.38%
Chest Pain: 6 people, 15.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.26%
Headache (pain in head): 4 people, 10.26%
Sleep Disorder: 4 people, 10.26%
Diarrhea: 4 people, 10.26%
Colitis (inflammation of colon): 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and Folvite?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously